Sanofi research demonstrates 9.3% reduction in all-cause healthcare resource utilization rates, including 23.5% decrease in hospitalization for dario users

Retrospective cohort study presented at ispor analyzed real-world data of users and non-users of a digital health solution new york , may 9, 2023 /prnewswire/ -- dariohealth corp. (nasdaq: drio) ("dario" or the "company"), a leader in the global digital health market, announced today the presentation of research at ispor 2023 demonstrating significant reductions in healthcare resource utilization for dario users compared to non-users, the first study completed by sanofi u.s. ("sanofi") under its strategic agreement with dario. ispor, the leading global conference for health economics and outcomes research, is being held may 7 th – 10th in boston.
DRIO Ratings Summary
DRIO Quant Ranking